Description
- Is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
- ?Indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.